Concord Drugs Cash Flow Annual

Trade
BSE: 538965 | NSE: - | ISIN: INE858L01010 | Sector: Biotechnology & Drugs
34.75 -1.25 (-3.47%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 0.631.252.254.29
Depreciation/ Depletion 1.561.631.761.37
Non- Cash Items 1.861.631.401.24
Changesin Working Capital -3.25-2.84-4.64-5.28
Cashfrom Operating Activities 0.791.660.771.62
Capital Expenditures -1.02-0.860.00-3.67
Other Investing Cash Flow Items Total 0.01-1.410.010.01
Cashfrom Investing Activities -1.01-2.270.01-3.67
Financing Cash Flow Items -0.86-1.07-1.78-1.33
Issuance( Retirement)of Stock Net 0.681.89-0.00
Issuance( Retirement)of Debt Net 0.46-0.193.463.41
Cashfrom Financing Activities 0.280.621.682.07
Net Changein Cash 0.070.022.470.02
Cash Interest Paid 1.871.641.411.25
Cash Taxes Paid 0.220.380.670.47
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,504.70+44.10(1.79%)
1,921.85+32.70(1.73%)
589.05+6.30(1.08%)
11,105.00-351.85 (-3.07%)
HomeMarketsPremiumInstant LoanMint Shorts